These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6886999)

  • 1. Fraction unbound in interstitial fluid.
    McNamara PJ; Gibaldi M; Stoeckel K
    J Pharm Sci; 1983 Jul; 72(7):834-6. PubMed ID: 6886999
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein binding of drugs in plasma, interstitial fluid and tissues: effect on pharmacokinetics.
    Faed EM
    Eur J Clin Pharmacol; 1981; 21(1):77-81. PubMed ID: 7333350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein binding of drugs.
    Heald AF; Singhvi SM
    Ann Clin Lab Sci; 1978; 8(3):239-43. PubMed ID: 655609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An electronic simulator for demonstration of pharmacokinetic concentration patterns].
    Bättig P
    Arzneimittelforschung; 1972 Mar; 22(3):603-6. PubMed ID: 5067940
    [No Abstract]   [Full Text] [Related]  

  • 5. Physiologic pharmacokinetic models: relevance, experience, and future trends.
    Rowland M
    Drug Metab Rev; 1984; 15(1-2):55-74. PubMed ID: 6378562
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogeneity of interstitial fluid space demonstrated by simultaneous kinetic analysis of the distribution and elimination of inulin and gallamine.
    Henthorn TK; Avram MJ; Frederiksen MC; Atkinson AJ
    J Pharmacol Exp Ther; 1982 Aug; 222(2):389-94. PubMed ID: 7097559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra- and extra-cellular formation of metabolites from chemically reactive species.
    Gillette JR; Lau SS; Monks TJ
    Biochem Soc Trans; 1984 Feb; 12(1):4-7. PubMed ID: 6705984
    [No Abstract]   [Full Text] [Related]  

  • 8. On pharmacokinetics in target tissues.
    Weiss M
    Biopharm Drug Dispos; 1985; 6(1):57-66. PubMed ID: 3986301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity.
    Nicholson C
    Brain Res; 1985 May; 333(2):325-9. PubMed ID: 3995298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.
    Mais RF; Keresztes-Nagy S; Zaroslinski JF; Oester YT
    J Pharm Sci; 1974 Sep; 63(9):1423-7. PubMed ID: 4427265
    [No Abstract]   [Full Text] [Related]  

  • 12. Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis.
    Huang JD
    J Pharm Sci; 1983 Nov; 72(11):1368-9. PubMed ID: 6644611
    [No Abstract]   [Full Text] [Related]  

  • 13. The bioanalytical challenge of determining unbound concentration and protein binding for drugs.
    Nilsson LB
    Bioanalysis; 2013 Dec; 5(24):3033-50. PubMed ID: 24320129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physicochemical mechanisms of the organotropism of drugs].
    Sergeev PV; Shimanovskiĭ NL
    Vestn Akad Med Nauk SSSR; 1984; (11):85-8. PubMed ID: 6397000
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacokinetics (second of two parts).
    Greenblatt DJ; Koch-Weser J
    N Engl J Med; 1975 Nov; 293(19):964-70. PubMed ID: 1101062
    [No Abstract]   [Full Text] [Related]  

  • 16. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of in silico models for fraction of unbound drug in human liver microsomes.
    Gao H; Steyn SJ; Chang G; Lin J
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):533-42. PubMed ID: 20233033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of extracellular protein binding on passive and active drug transport across Caco-2 cells.
    Neuhoff S; Artursson P; Zamora I; Ungell AL
    Pharm Res; 2006 Feb; 23(2):350-9. PubMed ID: 16388407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the volumes of distribution of basic drugs in humans based on data from animals.
    Sawada Y; Hanano M; Sugiyama Y; Harashima H; Iga T
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):587-96. PubMed ID: 6533294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicompartment-kinetics and the accumulation plateau.
    van Rossum JM; Tomey AH
    Arch Int Pharmacodyn Ther; 1970 Nov; 188(1):200-3. PubMed ID: 5485099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.